Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SPRY compared with MLYS: revenue, margins and what each company keeps, and the suppliers and customers both name
SPRY
ARS Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
MLYS
Mineralys Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SPRY
ARS Pharmaceuticals, Inc.
vs
MLYS
Mineralys Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
SPRY
ARS Pharmaceuticals, Inc.
Change
3.05
▼
−0.16%
· post 3.05
· delayed
Mkt cap
$336.1M
Revenue
$34M
Q2 FY26
Revenue
$84M
FY25
MLYS
Mineralys Therapeutics, Inc.
Change
15.96
▲
+2.62%
· post 15.96
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$1.4B
Revenue
—
Revenue
—
vs
Compare
After hours
Nov 3 '26
delayed
SPRY
ARS Pharmaceuticals, Inc.
vs
MLYS
Mineralys Therapeutics, Inc.
3.05
▼
−0.16%
post 3.05
delayed
Price
15.96
▲
+2.62%
post 15.96
delayed
$336.1M
Mkt cap
$1.4B
Q2 FY26
$34M
Revenue
—
FY25
$84M
Revenue
—
Change
Change
SPRY
3.05
▼
−0.16%
vs
MLYS
15.96
▲
+2.62%
After hours
Nov 3 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
SPRY: latest quarter is a loss; flow not drawable. MLYS: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only SPRY
18
—
ALK
unlisted
supplier
—
ALK U.S
unlisted
supplier
—
Recordati Ireland
unlisted
supplier
—
Aegis Therapeutics
unlisted
supplier
14 more · SPRY chain
›
Shared
0
No shared counterparties.
Only MLYS
1
—
Tanabe Pharma Corporation (Tanabe)
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SPRY, solid
MLYS, dashed